06/19/2026
For individuals with the APOE4 gene—the strongest genetic risk factor for Alzheimer's disease—the question of whether omega-3 supplements can protect the brain has been a major area of research.
A new clinical trial led by USC Center For Personalized Brain Health Director Dr. Hussein N. Yassine provides an important answer. While high-dose DHA supplementation successfully increased omega-3 levels in the brain, it did not improve memory, cognition, or brain volume in participants with multiple dementia risk factors.
The findings do not suggest that omega-3s are unimportant. Rather, they reinforce a growing theme in Alzheimer's prevention: nutrients do not operate in isolation. APOE4 risk appears to be profoundly influenced by the broader health environment—including physical activity, cardiovascular health, sleep, diet quality, metabolic health, and inflammation.
For APOE4 carriers, optimizing brain health is unlikely to come from a single supplement. Instead, the evidence increasingly points toward a comprehensive, personalized approach that addresses multiple risk factors simultaneously.
Read more about what this study means—and what it does not mean—for omega-3s, APOE4, and dementia prevention. ⬇️
Taking an omega-3 fatty acid supplement did not improve memory, cognitive function or brain cell loss for many people, a surprising new study finds.
